CardiologyDepartment, Trakya University, Edirne.
Cardiology Department, Derindere Hospital, Istanbul.
Monaldi Arch Chest Dis. 2021 Mar 12;91(2). doi: 10.4081/monaldi.2021.1718.
Over recent decades, systemic inflammation as quantified with inflammation markers or indices has been extensively investigated in the setting of various cardiovascular conditions including heart failure (HF), acute coronary syndromes (ACS). In contrast, systemic inflammation in patients with takotsubo syndrome (TTS) has been an underrated phenomenon in clinical practice. On the other hand, experimental and clinical data have been rapidly accumulating in the recent years regarding pathogenetic, prognostic as well as therapeutic implications of systemic inflammation in TTS. Accordingly, the present article aims to provide a general perspective on mechanistic and clinical aspects of systemic inflammation in the setting of TTS.
近几十年来，人们广泛研究了各种心血管疾病（包括心力衰竭[HF]和急性冠状动脉综合征[ACS]）中用炎症标志物或指数量化的系统性炎症。相比之下，在应激性心肌病（TTS）患者中，系统性炎症在临床实践中一直被低估。另一方面，近年来关于 TTS 中系统性炎症的发病机制、预后和治疗意义的实验和临床数据迅速积累。因此，本文旨在提供一个关于 TTS 中系统性炎症的机制和临床方面的总体观点。
